Literature DB >> 23337131

Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.

Li-Tzy Wu1, Kenneth R Gersing, Marvin S Swartz, Bruce Burchett, Ting-Kai Li, Dan G Blazer.   

Abstract

OBJECTIVE: To examine prevalences of substance use disorders (SUD) and comprehensive patterns of comorbidities among psychiatric patients ages 18-64 years (N = 40,099) in an electronic health records (EHR) database.
METHOD: DSM-IV diagnoses among psychiatric patients in a large university system were systematically captured: SUD, anxiety (AD), mood (MD), personality (PD), adjustment, childhood-onset, cognitive/dementia, dissociative, eating, factitious, impulse-control, psychotic (schizophrenic), sexual/gender identity, sleep, and somatoform diagnoses. Comorbidities and treatment types among patients with a SUD were examined.
RESULTS: Among all patients, 24.9% (n = 9984) had a SUD, with blacks (35.2%) and Hispanics (32.9%) showing the highest prevalence. Among patients with a SUD, MD was prevalent across all age groups (50.2-56.6%). Patients aged 18-24 years had elevated odds of comorbid PD, adjustment, childhood-onset, impulse-control, psychotic, and eating diagnoses. Females had more PD, AD, MD, eating, and somatoform diagnoses, while males had more childhood-onset, impulse-control, and psychotic diagnoses. Blacks had greater odds than whites of psychotic and cognitive/dementia diagnoses, while whites exhibited elevated odds of PA, AD, MD, childhood-onset, eating, somatoform, and sleep diagnoses. Women, blacks, and Native American/multiple-race adults had elevated odds of using inpatient treatment; men, blacks, and Hispanics had increased odds of using psychiatric emergency care. Comorbid MD, PD, adjustment, somatoform, psychotic, or cognitive/dementia diagnoses increased inpatient treatment.
CONCLUSION: Patients with a SUD, especially minority members, use more inpatient or psychiatric emergency care than those without. Findings provide evidence for research on understudied diagnoses and underserved populations in the real-world clinical settings.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23337131      PMCID: PMC3581730          DOI: 10.1016/j.jpsychires.2012.12.009

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  51 in total

1.  The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations.

Authors:  Philip C Kendall; Ronald C Kessler
Journal:  J Consult Clin Psychol       Date:  2002-12

Review 2.  Consequences of adolescent drug use on psychiatric disorders in early adulthood.

Authors:  J S Brook; L Richter; E Rubenstone
Journal:  Ann Med       Date:  2000-09       Impact factor: 4.709

3.  Documentation and coding of ED patient encounters: an evaluation of the accuracy of an electronic medical record.

Authors:  Eric Silfen
Journal:  Am J Emerg Med       Date:  2006-10       Impact factor: 2.469

4.  Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Authors:  Daniel J Foti; Roman Kotov; Lin T Guey; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

5.  Racial and ethnic differences in utilization of mental health services among high-risk youths.

Authors:  Ann F Garland; Anna S Lau; May Yeh; Kristen M McCabe; Richard L Hough; John A Landsverk
Journal:  Am J Psychiatry       Date:  2005-07       Impact factor: 18.112

6.  Social and clinical factors associated with psychiatric emergency service use and civil commitment among African-American youth.

Authors:  Michael A Lindsey; Sean Joe; Jordana Muroff; Briggett E Ford
Journal:  Gen Hosp Psychiatry       Date:  2010-02-04       Impact factor: 3.238

7.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

8.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 9.  The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings.

Authors:  M G Kushner; K Abrams; C Borchardt
Journal:  Clin Psychol Rev       Date:  2000-03

10.  Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.

Authors:  M D Glantz; J C Anthony; P A Berglund; L Degenhardt; L Dierker; A Kalaydjian; K R Merikangas; A M Ruscio; J Swendsen; R C Kessler
Journal:  Psychol Med       Date:  2008-12-02       Impact factor: 7.723

View more
  13 in total

1.  Representation of Drug Use in Biomedical Standards, Clinical Text, and Research Measures.

Authors:  Elizabeth W Carter; Indra Neil Sarkar; Genevieve B Melton; Elizabeth S Chen
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

2.  Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.

Authors:  Li-Tzy Wu; Udi E Ghitza; Bryan C Batch; Michael J Pencina; Leoncio Flavio Rojas; Benjamin A Goldstein; Tony Schibler; Ashley A Dunham; Shelley Rusincovitch; Kathleen T Brady
Journal:  Drug Alcohol Depend       Date:  2015-09-12       Impact factor: 4.492

Review 3.  Informatics and machine learning to define the phenotype.

Authors:  Anna Okula Basile; Marylyn DeRiggi Ritchie
Journal:  Expert Rev Mol Diagn       Date:  2018-02-16       Impact factor: 5.225

4.  Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.

Authors:  Bradley D Stein; Joshua Mendelsohn; Adam J Gordon; Andrew W Dick; Rachel M Burns; Mark Sorbero; Regina A Shih; Rosalie Liccardo Pacula
Journal:  J Addict Dis       Date:  2016-07-22

5.  Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.

Authors:  Li-Tzy Wu; Dan G Blazer; Kenneth R Gersing; Bruce Burchett; Marvin S Swartz; Paolo Mannelli
Journal:  J Psychiatr Res       Date:  2013-09-09       Impact factor: 4.791

6.  Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study.

Authors:  Li-Tzy Wu; Kathleen T Brady; Paolo Mannelli; Therese K Killeen
Journal:  J Psychiatr Res       Date:  2013-12-01       Impact factor: 4.791

7.  Multiple drug use disorder diagnoses among drug-involved hospitalizations in the United States: Results from the 2016 National Inpatient Sample.

Authors:  He Zhu; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2020-06-12       Impact factor: 4.492

8.  Comorbidity in Adult Patients Hospitalized with Type 2 Diabetes in Northeast China: An Analysis of Hospital Discharge Data from 2002 to 2013.

Authors:  Hui Chen; Yaoyun Zhang; Di Wu; Chunxiu Gong; Qing Pan; Xiao Dong; Yonghui Wu; Kuan Zhang; Shiping Wang; Jianbo Lei; Hua Xu
Journal:  Biomed Res Int       Date:  2016-10-25       Impact factor: 3.411

9.  Big data are coming to psychiatry: a general introduction.

Authors:  Scott Monteith; Tasha Glenn; John Geddes; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2015-09-29

10.  Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes.

Authors:  Li-Tzy Wu; Udi E Ghitza; He Zhu; Susan Spratt; Marvin Swartz; Paolo Mannelli
Journal:  Drug Alcohol Depend       Date:  2018-03-03       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.